Guardant Health saw a positive improvement to its Relative Strength (RS) Rating on Thursday, rising from 70 to 82.
This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the last 52 weeks stacks up against all the other stocks in our database.
Decades of market research reveals that the best stocks tend to have an RS Rating of at least 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Guardant Health is trying to complete a cup without handle with a 37.04 entry. See if it can break out in heavy trade.
The company reported 0% earnings growth last quarter. Revenue gains came in at 34%.
The company earns the No. 11 rank among its peers in the Medical-Services industry group. Hims & Hers Health, Castle Biosciences and Sotera Health are among the top 5 highly rated stocks within the group.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
